全文获取类型
收费全文 | 556篇 |
免费 | 64篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 7篇 |
妇产科学 | 4篇 |
基础医学 | 48篇 |
口腔科学 | 2篇 |
临床医学 | 46篇 |
内科学 | 220篇 |
皮肤病学 | 8篇 |
神经病学 | 90篇 |
特种医学 | 36篇 |
外科学 | 61篇 |
综合类 | 16篇 |
预防医学 | 32篇 |
眼科学 | 16篇 |
药学 | 23篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 11篇 |
2022年 | 9篇 |
2021年 | 18篇 |
2020年 | 16篇 |
2019年 | 18篇 |
2018年 | 34篇 |
2017年 | 22篇 |
2016年 | 14篇 |
2015年 | 25篇 |
2014年 | 23篇 |
2013年 | 34篇 |
2012年 | 41篇 |
2011年 | 47篇 |
2010年 | 29篇 |
2009年 | 25篇 |
2008年 | 39篇 |
2007年 | 34篇 |
2006年 | 34篇 |
2005年 | 26篇 |
2004年 | 22篇 |
2003年 | 32篇 |
2002年 | 15篇 |
2001年 | 9篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1997年 | 3篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1986年 | 4篇 |
1985年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1968年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1964年 | 1篇 |
1963年 | 1篇 |
1960年 | 1篇 |
1957年 | 2篇 |
1954年 | 2篇 |
1928年 | 1篇 |
排序方式: 共有623条查询结果,搜索用时 15 毫秒
1.
Aboudola S Kotloff KL Kyne L Warny M Kelly EC Sougioultzis S Giannasca PJ Monath TP Kelly CP 《Infection and immunity》2003,71(3):1608-1610
There is a strong association between serum antibody responses to toxin A and protection against Clostridium difficile diarrhea. A parenteral C. difficile toxoid vaccine induced very-high-level responses to anti-toxin A immunoglobulin G (IgG) in the sera of healthy volunteers. After vaccination, the concentrations of anti-toxin A IgG in the sera of all 30 recipients exceeded the concentrations that were associated with protection in previous clinical studies. Furthermore, the median concentration of serum anti-toxin A IgG in the test group was 50-fold higher than the previous threshold. These findings support the feasibility of using a vaccine to protect high-risk individuals against C. difficile-associated diarrhea and colitis. 相似文献
2.
3.
4.
Eoin Moynihan Katrina Mackey Mark A. T. Blaskovich F. Jerry Reen Gerard McGlacken 《ACS medicinal chemistry letters》2022,13(8):1358
Antibiotic resistance has grown significantly in the last three decades, while research and development of new antibiotic classes has languished. Therefore, new chemical frameworks for the control of microbial behavior are urgently required. This study presents a novel suite of compounds, based on a tricyclic 4-hydroxy-2H-pyrano[3,2-c]quinoline-2,5(6H)-dione core, with significant antibiotic activity against the ESKAPE pathogens Staphylococcus aureus and Enterococcus faecalis and the “accidental pathogen” Staphylococcus epidermidis. A potent analogue with an N-heptyl-9-t-Bu substitution pattern emerged as a hit with MIC levels ≤2 μg/mL across four strains of MRSA. In addition, the same compound proved highly potent against Enterococcus spp. (0.25 μg/mL). 相似文献
5.
6.
7.
Li Y Boggia J Thijs L Hansen TW Kikuya M Björklund-Bodegård K Richart T Ohkubo T Kuznetsova T Torp-Pedersen C Lind L Ibsen H Imai Y Wang J Sandoya E O'brien E Staessen JA;International Database on Ambulatory Blood Pressure Monitoring in relation to Cardiovascular Outcomes Investigators 《Blood pressure monitoring》2008,13(3):145-147
The objective of this study was to investigate the prognostic significance of the ambulatory blood pressure (BP) during night and day and of the night-to-day BP ratio (NDR). We studied 7458 participants (mean age 56.8 years; 45.8% women) enrolled in the International Database on Ambulatory BP in relation to Cardiovascular Outcome. Using Cox models, we calculated hazard ratios (HR) adjusted for cohort and cardiovascular risk factors. Over 9.6 years (median), 983 deaths and 943 cardiovascular events occurred. Nighttime BP predicted mortality outcomes (HR, 1.18-1.24; P<0.01) independent of daytime BP. Conversely, daytime systolic (HR, 0.84; P<0.01) and diastolic BP (HR, 0.88; P<0.05) predicted only noncardiovascular mortality after adjustment for nighttime BP. Both daytime BP and nighttime BP consistently predicted all cardiovascular events (HR, 1.11-1.33; P<0.05) and stroke (HR, 1.21-1.47; P<0.01). Daytime BP lost its prognostic significance for cardiovascular events in patients on antihypertensive treatment. Adjusted for the 24-h BP, NDR predicted mortality (P<0.05), but not fatal combined with nonfatal events. Participants with systolic NDR of at least 1 compared with participants with normal NDR (> or = 0.80 to <0.90) were older, at higher risk of death, but died at higher age. The predictive accuracy of the daytime and nighttime BP and the NDR depended on the disease outcome under study. The increased mortality in patients with higher NDR probably indicates reverse causality. Our findings support recording the ambulatory BP during the whole day. 相似文献
8.
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial 总被引:6,自引:0,他引:6
Staessen JA Thijisq L Fagard R Celis H Birkenhäger WH Bulpitt CJ de Leeuw PW Fletcher AE Forette F Leonetti G McCormack P Nachev C O'Brien E Rodicio JL Rosenfeld J Sarti C Tuomilehto J Webster J Yodfat Y Zanchetti A;Systolic Hypertension in Europe 《Journal of hypertension》2004,22(4):847-857
BACKGROUND: To assess the impact of immediate versus delayed antihypertensive treatment on the outcome of older patients with isolated systolic hypertension, we extended the double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial by an open-label follow-up study lasting 4 years. METHODS: The Syst-Eur trial included 4695 randomized patients with minimum age of 60 years and an untreated blood pressure of 160-219 mmHg systolic and below 95 mmHg diastolic. The double-blind trial ended after a median follow-up of 2.0 years (range 1-97 months). Of 4409 patients still alive, 3517 received open-label treatment consisting of nitrendipine (10-40 mg daily) with the possible addition of enalapril (5-20 mg daily), hydrochlorothiazide (12.5-25 mg daily), or both add-on drugs. Non-participants (n = 892) were also followed up. RESULTS: Median follow-up increased to 6.1 years. Systolic pressure decreased to below 150 mmHg (target level) in 2628 participants (75.0%). During the 4-year open-label follow-up, stroke and cardiovascular complications occurred at similar frequencies in patients formerly randomized to placebo and those continuing active treatment. These rates were similar to those previously observed in the active-treatment group during the double-blind trial. Considering the total follow-up of 4695 randomized patients, immediate compared with delayed antihypertensive treatment reduced the occurrence of stroke and cardiovascular complications by 28% (P = 0.01) and 15% (P = 0.03), respectively, with a similar tendency for total mortality (13%, P = 0.09). In 492 diabetic patients, the corresponding estimates of long-term benefit (P < 0.02) were 60, 51 and 38%, respectively. CONCLUSIONS: Antihypertensive treatment can achieve blood pressure control in most older patients with isolated systolic hypertension. Immediate compared with delayed treatment prevented 17 strokes or 25 major cardiovascular events per 1000 patients followed up for 6 years. These findings underscore the necessity of early treatment of isolated systolic hypertension. 相似文献
9.
10.